tm
Seeing Is Believing
tm
Seeing Is Believing
ELEV is currently covered by 3 analysts
Elevation Oncology's activity chart (see below) currently has 3 price targets and 15 ratings on display. The stock rating distribution of ELEV is 30% HOLD, 10% SELL and 60% BUY.
Analysts average stock forecasts to be materialized ratio is 27.78% with an average time for these price targets to be met of 41.67 days.
Highest price target for ELEV is $5, Lowest price target is $1.
Most recent stock forecast was given by ROBERT DRISCOLL from WEDBUSH on 03-May-2024. First documented stock forecast 20-Jul-2021.
Currently out of the existing stock ratings of ELEV, 3 are a HOLD (30%), 1 are a SELL (10%), 6 are a BUY (60%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$8
$5.63 (237.55%)
$8
2 years 4 months 7 days ago
(03-May-2024)
1/6 (16.67%)
$4.3 (116.22%)
59
Buy
$8
$5.63 (237.55%)
$1
3 years 3 months 11 days ago
(30-May-2023)
2/3 (66.67%)
$3.65 (83.91%)
66
Sell
3 years 10 months ago
(10-Nov-2022)
0/1 (0%)
$12.36 (106.19%)
What is ELEV (Elevation Oncology) average time for price targets to be met?
Which analyst most recently updated their price target on ELEV (Elevation Oncology)?
Which analyst has the current lower performing score on ELEV (Elevation Oncology) with a proven track record?
Which analyst has the most public recommendations on ELEV (Elevation Oncology)?
Which analyst is the currently most bullish on ELEV (Elevation Oncology)?
Which analyst is the currently most reserved on ELEV (Elevation Oncology)?
